Testing a new medication for moderate to severe lupus

Plain-English translation of NCT07409181 on ClinicalTrials.gov ↗ · Source last updated October 2026 · Translation generated October 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

What is this trial?

This trial is testing a new medication called to see if it can help people with moderate to severe lupus (a condition where the immune system attacks the body). About 405 people will be randomly assigned to take one of four different doses of the medication or a placebo (a pill with no medicine in it) for one year. Everyone continues their regular lupus treatments while taking part.

Lupus is a serious autoimmune disease that can cause pain, inflammation, and organ damage, and current treatment options don't work well enough for everyone. This trial is testing whether this new medication can reduce lupus symptoms and disease activity better than what's currently available.

Do you qualify?

You likely qualify if…

you are between 18 and 75 years old
you have been diagnosed with lupus at least 24 weeks before entering the study
you have moderate to severe lupus disease activity as measured by standard medical tests
you have been on your regular lupus medications at a stable dose for several weeks before starting the trial
you have specific antibodies in your blood that confirm lupus (such as ANA or anti-dsDNA)

You likely don't qualify if…

you have lupus caused by a medication rather than by your immune system
you have certain neurological complications of lupus that are active or unstable
you have severe kidney involvement from lupus with unstable function
you are taking high doses of oral corticosteroids (prednisone or equivalent) above 30 mg per day
you have other connective tissue diseases that would make it hard to measure lupus activity

What participation looks like

You will take a tablet by mouth every day for one year, continuing your regular lupus medications at the same dose. You will visit the study clinic regularly so doctors can check your health, run blood tests, and watch for any side effects. The entire study lasts a bit longer than one year, during which the research team will compare your results with others in the study to see if the medication helps.

AI-generated summary from trial data · Oct 6, 2026 · Not medical advice

Testing a new medication for moderate to severe lupus

What is this trial?

Do you qualify?

What participation looks like

Trial locations